3 Areas of Opportunity for Private Equity Investment in Life Sciences


The life sciences investment space has been largely immune to the negative impacts of the COVID-19 pandemic. Growth in the pharmaceutical, biotechnology and medical device industries has led to increased interest from private equity investors, many of which are new to the life sciences market.

In this video we address:

  • Three areas ripe for private equity investment in the life sciences arena
  • Sector-specific due diligence concerns investors should address
  • Opportunities for ROI when investing in life sciences and life sciences adjacent companies

Dig Deeper

Webinar / American Conference Institutes (ACI) / September 29-30, 2021

ACI's FDA Boot Camp

Webinar / VIRGO / June 30, 2021

VIRGO's The Future of Healthcare

Webinar / Speaking Engagements / June 24, 2021

Atlanta – Belfast Connect Invitation to Explore

Two Day Virtual Event / McDermott Event / June 23-24, 2021

HPE Europe 2021

Get In Touch